Society

Australian Tribunal Asked: Are Puberty Blockers a Human Right?

The battle over transgender treatments is playing an increasingly prominent role in Australia’s volatile politics – and now the legal system is being drawn into the fight in a major way.

Transgender culture war in Australia.

In Australia, the transgender culture war is increasingly being fought in the legal arena as well as the political one. Photo: Lisa Maree Williams/Getty Images

Is the state obligated to provide cross-sex hormones and puberty blockers to children, even when policymakers are opposed to the idea? That is the question that an Australian tribunal is being asked to answer in a class-action-type suit taken – nominally – on behalf of up to 500 children in the state of Queensland.

The case – in which the litigation is set to be led by the taxpayer-funded Queensland LGBTI Legal Service – seeks to reverse a decision by the state government, which is run by the conservative-oriented Liberal National Party. That decision, in January 2025, suspended the provision of puberty blockers to children other than those who had already commenced a course of treatment. It is this suspension that the tribunal is now being asked to overturn.

The case also includes a claim for damages, with each child seeking up to A$50,000 ($36,000) for emotional trauma and related harms.

More Than the Usual Questions

The questions at stake in the case, however, go well beyond the normal transgender culture-war battle and ask something more fundamental about the relationship between voters, politicians and the legal system. Specifically, a ruling in favor of the applicant children would mean that the government, in effect, would be compelled to provide, at taxpayer expense, a treatment that neither it nor, presumably, its voters approved of.

Welcome to the comments section of the Štandard daily. Please take note of our guidelines, comments are moderated by us. You can contact the moderators at support@statement.com.

Participate in the discussion

Comments are available to subscribers only. If you'd like to join the discussion, choose a subscription starting at €6.72 per month.

All comments 0

    Register

    Comments are available to registered users only. If you'd like to join the discussion, register here.